- Home
- OTRK vs SLRX Comparison
OTRK vs SLRX Comparison
Compare OTRK & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTRK
- SLRX
- Stock Information
- Founded
- OTRK 2003
- SLRX N/A
- Country
- OTRK United States
- SLRX United States
- Employees
- OTRK N/A
- SLRX N/A
- Industry
- OTRK Misc Health and Biotechnology Services
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- OTRK Health Care
- SLRX Health Care
- Exchange
- OTRK Nasdaq
- SLRX Nasdaq
- Market Cap
- OTRK 2.1M
- SLRX 2.1M
- IPO Year
- OTRK N/A
- SLRX N/A
- Fundamental
- Price
- OTRK $0.44
- SLRX $0.55
- Analyst Decision
- OTRK Strong Buy
- SLRX
- Analyst Count
- OTRK 1
- SLRX 0
- Target Price
- OTRK $3.00
- SLRX N/A
- AVG Volume (30 Days)
- OTRK 10.7M
- SLRX 6.2M
- Earning Date
- OTRK 08-19-2025
- SLRX 08-19-2025
- Dividend Yield
- OTRK N/A
- SLRX N/A
- EPS Growth
- OTRK N/A
- SLRX N/A
- EPS
- OTRK N/A
- SLRX N/A
- Revenue
- OTRK $10,183,000.00
- SLRX N/A
- Revenue This Year
- OTRK $6.40
- SLRX N/A
- Revenue Next Year
- OTRK $95.50
- SLRX N/A
- P/E Ratio
- OTRK N/A
- SLRX N/A
- Revenue Growth
- OTRK N/A
- SLRX N/A
- 52 Week Low
- OTRK $0.23
- SLRX $0.45
- 52 Week High
- OTRK $5.53
- SLRX $7.20
- Technical
- Relative Strength Index (RSI)
- OTRK 42.56
- SLRX 41.63
- Support Level
- OTRK $0.31
- SLRX $0.46
- Resistance Level
- OTRK $0.63
- SLRX $2.31
- Average True Range (ATR)
- OTRK 0.11
- SLRX 0.18
- MACD
- OTRK 0.02
- SLRX -0.01
- Stochastic Oscillator
- OTRK 48.84
- SLRX 4.97
About OTRK Ontrak Inc.
Ontrak Inc is an artificial intelligence (AI)-powered and technology-enabled behavioral healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. The group provides a value-based behavioral healthcare company that identifies and engages people with unmet health needs using the proprietary Advanced Engagement System to improve clinical outcomes and reduce total cost of care. The company's integrated, technology-enabled OntrakTM solutions, a component of the PRE platform, are designed to treat members with behavioral conditions that cause chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.